Literature DB >> 20877542

The rationale behind topical vitamin d analogs in the treatment of psoriasis: where does topical calcitriol fit in?

Grace K Kim1.   

Abstract

Entities:  

Year:  2010        PMID: 20877542      PMCID: PMC2945865     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


× No keyword cloud information.
  39 in total

1.  Topical corticosteroid phobia in patients with atopic eczema.

Authors:  C R Charman; A D Morris; H C Williams
Journal:  Br J Dermatol       Date:  2000-05       Impact factor: 9.302

2.  Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study.

Authors:  J Ring; L Kowalzick; E Christophers; W B Schill; E Schöpf; M Ständer; H H Wolff; P Altmeyer
Journal:  Br J Dermatol       Date:  2001-03       Impact factor: 9.302

Review 3.  Treatment of psoriasis. Part 1. Topical therapy and phototherapy.

Authors:  M Lebwohl; S Ali
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

Review 4.  Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.

Authors:  L Kowalzick
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

5.  Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

Authors:  J Koo
Journal:  Dermatol Clin       Date:  1996-07       Impact factor: 3.478

Review 6.  Role of the vitamin D3 pathway in healthy and diseased skin--facts, contradictions and hypotheses.

Authors:  Bodo Lehmann
Journal:  Exp Dermatol       Date:  2009-02       Impact factor: 3.960

Review 7.  Calcitriol ointment: optimizing psoriasis therapy.

Authors:  Linda F Stein Gold
Journal:  J Drugs Dermatol       Date:  2009-08       Impact factor: 2.114

Review 8.  The role of topical vitamin D modulators in psoriasis therapy.

Authors:  Emil A Tanghetti
Journal:  J Drugs Dermatol       Date:  2009-08       Impact factor: 2.114

9.  Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.

Authors:  J M Camarasa; J-P Ortonne; L Dubertret
Journal:  J Dermatolog Treat       Date:  2003-01       Impact factor: 3.359

10.  The direct cost of care for psoriasis and psoriatic arthritis in the United States.

Authors:  Harold S Javitz; Marcia M Ward; Eugene Farber; Lexie Nail; Susan Gillis Vallow
Journal:  J Am Acad Dermatol       Date:  2002-06       Impact factor: 11.527

View more
  7 in total

Review 1.  Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 2.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.

Authors:  Ana M Martins; Andreia Ascenso; Helena Margarida Ribeiro; Joana Marto
Journal:  Mol Neurobiol       Date:  2020-02-15       Impact factor: 5.590

Review 3.  Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis.

Authors:  Heng T Chong; Zlatko Kopecki; Allison J Cowin
Journal:  Biomed Res Int       Date:  2013-08-25       Impact factor: 3.411

Review 4.  Nonsteroidal Topical Immunomodulators in Allergology and Dermatology.

Authors:  Marina Jovanović; Zoran Golušin
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411

5.  Effect of Calcipotriol on IFN-γ-Induced Keratin 17 Expression in Immortalized Human Epidermal Keratinocyte Cells.

Authors:  Jieyu Zhang; Hui Fang; Ruoyang Wang; Erle Dang; Man Jiang; Gang Wang
Journal:  Med Sci Monit       Date:  2017-12-22

Review 6.  Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.

Authors:  Salma A Fereig; Ghada M El-Zaafarany; Mona G Arafa; Mona M A Abdel-Mottaleb
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 7.  Psoriasis and osteoporosis: a literature review.

Authors:  Dohyen Wi; Anna Wilson; Fanny Satgé; Dédée F Murrell
Journal:  Clin Exp Dermatol       Date:  2022-05-25       Impact factor: 4.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.